Ministry of Food and Drug Safety
Scope
Date
~
-
Bio & Pharma
Korea's InCerebro to leverage AI to identify drug candidates
South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...
Feb 01, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea's fisheries ministry to transfer tech on Napoleon fish to SE Asia
South Korea's Ministry of Oceans and Fisheries will transfer technology to Indonesia on farming the tropical Napoleon fish and reduce sea pollution ...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Banking & Finance
Korea's credit card approval volume hit all-time high last year
The annual card approval amount in South Korea exceeded 1,000 trillion won ($811.4 billion) for the first time ever. This is largely because of "ret...
Feb 01, 2023 (Gmt+09:00)
-
Airlines
T'way Air completes IOSA recertification process
South Korea's low-cost carrier T'way Air Co. said on Monday that it has completed the IATA Operational Safety Audit (IOSA) recertification from the ...
Jan 31, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to put AI into new drug ingredient development
South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...
Jan 30, 2023 (Gmt+09:00)
-
Shareholder activism
KT&G refuses activist funds' call for ginseng biz spinoff
KT&G Corp., the world’s fifth-largest tobacco maker, on Thursday refused activist funds' requests to spin off and list its ginseng unit wh...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Automobiles
Hyundai AutoEver secures international safety, health certification
South Korea's mobility software provider Hyundai AutoEver said Wednesday that it has earned the international safety and health management system IS...
Jan 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea’s top probiotic drink maker hy to expand global biz
South Korea’s leading probiotic drink maker hy Co. is seeking to expand its health functional food business into the global market as demand f...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's K-CAB to get insurance benefits in China
South Korea’s 30th novel medicine K-CAB Tab (active ingredient: tegoprazan), a gastroesophageal reflux disease (GERD) treatment of HK inno.N, ...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
ST Pharm exports $14.6 mn worth of drug ingredients to Europe
ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Sanfilippo treatment eligible for FDA priority review
GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong accelerates investment in CDMO business
Daewoong, the holding company of South Korea's pharmaceutical-oriented Daewoong Group, is speeding up its pace to beef up its contract development a...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Medipost completes first dose of Cartistem in phase 3 clinical trials in Japan
South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...
Jan 17, 2023 (Gmt+09:00)
-
Food & Beverage
K-chicken chain Kyochon signs MOU with Taiwanese food conglomerate
Kyochon F&B, the company operating Kyochon Chicken, said on Friday that it has signed a memorandum of understanding for a master franchise agree...
Jan 13, 2023 (Gmt+09:00)
-
Corporate strategy
SPC Group adopts integrated safety check system app for all biz sites
South Korea's SPC Group on Wednesday said it has developed an app for an integrated safety inspection system using information and communications te...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
JVM to sell fully automated drug inspection machines in US
Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug d...
Jan 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
Korean food
CJ CheilJedang to expand K-food production facilities overseas
South Korean food giant CJ CheilJedang Corp. is slated to increase food manufacturing facilities globally and launch businesses in Australia, Canada...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Onchorus to undertake research on mRNA anticancer drugs
Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...
Jan 05, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Novarex, Riman sign agreement to jointly develop health-functional food
South Korea's health functional foods company Novarex and cosmetics company Riiman Korea met to promote the health-functional foods business togethe...
Jan 04, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Sejong kicks off private 5G business for exclusive use for industrial safety
Sejong Telecom, Inc. a mid-sized facilities-based telecommunications business and ICT platform company in South Korea, will launch a private 5G bu...
Jan 03, 2023 (Gmt+09:00)
-
Business & Politics
Korea proposes bigger tax breaks for chipmakers, key industries
The South Korean government plans to raise tax breaks for facility investments by big companies, including chipmakers, to as much as 25% following P...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Korean startups
Silvia Health attracts investment through pre-Series A funding
Silvia Health Inc., an age-tech startup based in Seoul, South Korea said on Monday that it has completed a pre-Series A investment with the particip...
Jan 02, 2023 (Gmt+09:00)
-
IPOs
Morning food delivery firm Oasis passes Kosdaq listing eligibility review
Oasis Corp., which operates the early morning food delivery platform "Oasis Market," said it passed the eligibility review for listing at Kosdaq mar...
Dec 30, 2022 (Gmt+09:00)
Latest News
- 1 JLL, Savills to lead Seoul Square sale in $1 bn deal
- 2 Partners Group sees infrastructure secondaries quadrupling to $60 bn
- 3 MBK-invested Homeplus looks for new owner as M&A emerges as option
- 4 Hyundai Steel to displace Baoshan as GM Korea's supplier
- 5 S.Korea’s No.1 dried seaweed firm Kwangcheonkim on market for $295 mn